Endocrinology Research and Practice
Letter To the Editor

CHEK2 Mutation with Heterozygote c.592+3A>T Variant in a Patient with Early Breast and Papillary Thyroid Cancer

1.

Department of Endocrinology and Metabolism, Kocaeli City Hospital, Kocaeli, Türkiye

2.

Department of Genetics, Kocaeli City Hospital, Kocaeli, Türkiye

3.

Labgen Genetic Diagnosis Centre, Acıbadem Hospital Group, İstanbul, Türkiye

Endocrinol Res Pract 2025; 29: 283-284
DOI: 10.5152/erp.2025.25617
Read: 27 Downloads: 29 Published: 20 May 2025

Cite this article as: Caklili OT, Metli K, Basmaz SE, Kurt AMO, Yesilyurt A. CHEK2 mutation with heterozygote c.592+3A>T variant in a patient with early breast and papillary thyroid cancer. Endocrinol Res Pract. 2025;29(3):283-284.

Files
EISSN 2822-6135